Acquired by 22nd Century Group (NASDAQ:XXII) Acquires GVB Biopharma: Stock Jumps

May 16, 2022

22nd Century Group Inc. (NASDAQ:XXII) has acquired privately held GVB Biopharma, which is a contract development and manufacturing organization that is supposedly one of the biggest providers of hemp-derived active ingredients for the pharmaceutical and consumer goods industries globally, based on total tonnage. Trading Data On Friday, XXII stock surged 7% to $1.68 with more than 3.26 million shares, compared to its average volume of 1.56 million shares. The stock…